(Q42614801)

3 November 2017

title

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention (English)

1 reference

3 November 2017

1 reference

Stephen Landy

1 reference

3 November 2017

Rebecca Hoagland

series ordinal

1 reference

3 November 2017

Nancy A Hoagland

series ordinal

1 reference

3 November 2017

publication date

29 August 2011

1 reference

3 November 2017

1 reference

3 November 2017

1 reference

3 November 2017

1 reference

3 November 2017

page(s)

133-139

1 reference

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Sumatriptan-naproxen for acute treatment of migraine: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Improved identification of allodynic migraine patients using a questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Difference in triptan effect in patients with migraine and early allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01992.X

10.1111/J.1526-4610.2011.01992.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference